Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Adefovir

Drug Profile

Adefovir

Alternative Names: GS 0393; GS 393; Phosphonylmethoxyethyl-a; PMEA

Latest Information Update: 23 Sep 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Academy of Sciences of the Czech Republic; Nonindustrial source; Rega Institute for Medical Research
  • Developer Academy of Sciences of the Czech Republic; Gilead Sciences; Nonindustrial source
  • Class Adenine nucleotides; Antiretrovirals; Phosphonic acids; Purine nucleotides; Small molecules
  • Mechanism of Action Cell differentiation stimulants; DNA-directed DNA polymerase inhibitors; Immunomodulators; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer; Graft-versus-host disease; Hepatitis B; HIV infections; Rheumatic disorders

Most Recent Events

  • 08 May 2000 Discontinued-II for HIV infections treatment in USA (IV)
  • 08 May 2000 Discontinued-Preclinical for Hepatitis B in USA (Unknown route)
  • 22 Oct 1997 Preclinical development for Cancer in Belgium (Unknown route)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top